日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors

接受免疫检查点抑制剂治疗的重症肌无力患者

Alghabban, Abdulrahman; Corke, Lucy; Katzberg, Hans; Bril, Vera; Barnett-Tapia, Carolina; Mason, Warren; Alothman, Raed; Albiruni Ryan, Abdul Razak; Hogg, David; Sridhar, Srikala; Dhani, Neesha; Spreafico, Anna; Eng, Lawson; Sacher, Adrian; Bradbury, Penelope; Liu, Geoffrey; Leighl, Natasha; Shepherd, Frances A

Clinical activity of pembrolizumab in refractory MDM2-amplified advanced intimal sarcomas

帕博利珠单抗治疗难治性MDM2扩增晚期内膜肉瘤的临床活性

Ribeiro, Mauricio Fernando; Demicco, Elizabeth G; Razak, Albiruni Ryan Abdul

Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study

放射诱发肉瘤(RIS)的临床人口学特征和预后:一项CanSaRCC研究

Ribeiro, Mauricio Fernando; Peretz Soroka, Hagit; Bhura, Zainab; Hirsch, Ian; Wunder, Jay; Ferguson, Peter; Tsoi, Kim; Brar, Savtaj; Gladdy, Rebecca; Swallow, Carol; Chung, Peter; Catton, Charles; Wong, Philip; Watson, Geoffrey; Razak, Albiruni Ryan Abdul; Gupta, Abha A; Shultz, David

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma

Selinexor(一种首创的核输出抑制剂)治疗晚期难治性骨或软组织肉瘤患者的 IB 期研究

Gounder, Mrinal M; Zer, Alona; Tap, William D; Salah, Samer; Dickson, Mark A; Gupta, Abha A; Keohan, Mary Louise; Loong, Herbert H; D'Angelo, Sandra P; Baker, Stephanie; Condy, Mercedes; Nyquist-Schultz, Kjirsten; Tanner, Lanier; Erinjeri, Joseph P; Jasmine, Francis H; Friedlander, Sharon; Carlson, Robert; Unger, Thaddeus J; Saint-Martin, Jean-Richard; Rashal, Tami; Ellis, Joel; Kauffman, Michael; Shacham, Sharon; Schwartz, Gary K; Abdul Razak, Albiruni Ryan

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

针对早期、晚期和复发性成人恶性生殖细胞卵巢癌患者的化疗

Abdul Razak, Albiruni Ryan; Li, Louise; Bryant, Andrew; Diaz-Padilla, Ivan